Neurovascular medtech startup
Location: Ireland, Galway
Employees: 11-50
Total raised: $29.17M
Founded date: 2018
Investors 3
| Date | Name | Website |
| - | Earlybird ... | earlybird.... |
| 12.02.2022 | Seroba Lif... | seroba-lif... |
| 11.02.2022 | Life Scien... | lspvc.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.02.2022 | Series A | $25.74M | - |
| 29.01.2019 | Seed | $3.43M | Earlybird ... |
Mentions in press and media 14
| Date | Title | Description | Source |
| 20.12.2023 | Perfuze® Announces FDA Clearances for Novel Neurovascular As... | Galway, Ireland, December 20, 2023 –Perfuze, a private medical device company dedicated to developin... | svhealthin... |
| 10.11.2023 | Perfuze® Announces First Stroke Patient Enrolled in the MARR... | Galway, Ireland. 2 November 2023. Perfuze, a private medical device company dedicated to developing ... | seroba-lif... |
| 02.11.2023 | Perfuze Announces First Stroke Patient Enrolled in the MARRS... | Galway, Ireland, November 2, 2023 –Perfuze, a private medical device company dedicated to developing... | svhealthin... |
| 17.07.2023 | Earlybird Health's Inaugural Impact & ESG report reveals... | Whether you like it or not, you'll be hearing a lot about ESG (Environmental Social Governance) metr... | tech.eu/20... |
| 09.06.2023 | Perfuze Announces Appointment of New Chair of the Board. | Galway, Ireland. 9 June, 2023. Seroba portfolio company, Perfuze, a medical device company developin... | seroba-lif... |
| 16.02.2023 | Perfuze Announces FDA Clearance and First U.S. Clinical Use ... | Galway, Ireland. 16 February 2023. Perfuze, a medical device company developing next-generation cath... | seroba-lif... |
| 16.02.2023 | Perfuze Announces FDA Clearance and First U.S. Clinical Use ... | GALWAY, Ireland--(BUSINESS WIRE)--Perfuze, a medical device company developing next-generation cathe... | svhealthin... |
| 09.02.2022 | Galway stroke treatment medtech firm Perfuze raises €22.5m | Galway medical technology company Perfuze has raised €22.5m in funding on the back of its innovative... | businesspl... |
| 09.02.2022 | Neurovascular Company Perfuze Raises 22.5m ($25m) Series A ... | Perfuze, a medical device company developing next-generation catheter-based aspiration technology to... | marketscre... |
| 09.02.2022 | Neurovascular company Perfuze raises €22.5M ($25M) Series A ... | Galway, Ireland, February 9th, 2022 –Perfuze, a medical device company developing next-generation ca... | svhealthin... |
Show more